These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

113 related items for PubMed ID: 7663693

  • 1. Chemical synthesis of dioxygen-18 labelled omega-/beta-oxidized cysteinyl leukotrienes: analysis by gas chromatography-mass spectrometry and gas chromatography-tandem mass spectrometry.
    Tsikas D, Fauler J, Frölich JC.
    J Chromatogr B Biomed Appl; 1995 May 19; 667(2):209-21. PubMed ID: 7663693
    [Abstract] [Full Text] [Related]

  • 2. Peroxisomal degradation of leukotrienes by beta-oxidation from the omega-end.
    Jedlitschky G, Huber M, Völkl A, Müller M, Leier I, Müller J, Lehmann WD, Fahimi HD, Keppler D.
    J Biol Chem; 1991 Dec 25; 266(36):24763-72. PubMed ID: 1761571
    [Abstract] [Full Text] [Related]

  • 3. Metabolism of cysteinyl leukotrienes in monkey and man.
    Huber M, Müller J, Leier I, Jedlitschky G, Ball HA, Moore KP, Taylor GW, Williams R, Keppler D.
    Eur J Biochem; 1990 Nov 26; 194(1):309-15. PubMed ID: 2174780
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Pharmacological profile of leukotrienes E4, N-acetyl E4 and of four of their novel omega- and beta-oxidative metabolites in airways of guinea-pig and man in vitro.
    Samhoun MN, Conroy DM, Piper PJ.
    Br J Pharmacol; 1989 Dec 26; 98(4):1406-12. PubMed ID: 2558763
    [Abstract] [Full Text] [Related]

  • 6. Analysis of cysteinyl leukotrienes and leukotriene B4 by gas chromatography-(tandem) mass spectrometry.
    Tsikas D, Fauler J, Frölich JC.
    Eicosanoids; 1992 Dec 26; 5 Suppl():S7-9. PubMed ID: 1333256
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Enzymic preparation of dioxygen-18 labelled leukotriene E4 and its use in quantitative gas chromatography-mass spectrometry.
    Tsikas D, Fauler J, Frölich JC.
    J Chromatogr; 1992 Feb 14; 574(2):181-7. PubMed ID: 1320043
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Enhanced synthesis of cysteinyl leukotrienes in juvenile rheumatoid arthritis.
    Fauler J, Thon A, Tsikas D, von der Hardt H, Frölich JC.
    Arthritis Rheum; 1994 Jan 14; 37(1):93-7. PubMed ID: 8129769
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Impaired degradation of leukotrienes in patients with peroxisome deficiency disorders.
    Mayatepek E, Lehmann WD, Fauler J, Tsikas D, Frölich JC, Schutgens RB, Wanders RJ, Keppler D.
    J Clin Invest; 1993 Mar 14; 91(3):881-8. PubMed ID: 8450067
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Metabolism and excretion of exogenous [3H]-LTC4 in primates.
    Tagari P, Foster A, Delorme D, Girard Y, Rokach J.
    Prostaglandins; 1989 Jun 14; 37(6):629-40. PubMed ID: 2549573
    [Abstract] [Full Text] [Related]

  • 16. Peroxisomal leukotriene degradation: biochemical and clinical implications.
    Jedlitschky G, Mayatepek E, Keppler D.
    Adv Enzyme Regul; 1993 Jun 14; 33():181-94. PubMed ID: 8356907
    [Abstract] [Full Text] [Related]

  • 17. Assessment of cysteinyl leukotriene synthesis in man.
    Frölich JC, Fauler J, Tsikas D.
    J Lipid Mediat Cell Signal; 1994 Feb 14; 9(1):75-8. PubMed ID: 8032717
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Enhanced synthesis of cysteinyl leukotrienes in psoriasis.
    Fauler J, Neumann C, Tsikas D, Frölich J.
    J Invest Dermatol; 1992 Jul 14; 99(1):8-11. PubMed ID: 1318908
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.